Page last updated: 2024-08-25

rosiglitazone and Bone Marrow Diseases

rosiglitazone has been researched along with Bone Marrow Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benko, I; Benko, K; Djazayeri, K; Rózsa, B; Szabó, B; Szentmiklósi, AJ; Szilvássy, Z	1

Other Studies

1 other study(ies) available for rosiglitazone and Bone Marrow Diseases

Article	Year
Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil. Pharmacological research, 2006, Volume: 53, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Bone Regeneration; Female; Fluorouracil; Granulocytes; Hypoglycemic Agents; Leukocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutrophils; Rosiglitazone; Thiazolidinediones	2006

Article

Year

Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil.

Pharmacological research, 2006, Volume: 53, Issue:2

Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Diseases; Bone Regeneration; Female; Fluorouracil; Granulocytes; Hypoglycemic Agents; Leukocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutrophils; Rosiglitazone; Thiazolidinediones

2006